Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at ...
Argobio Studio, the launch platform for Europe's best innovative science, today announced the successful seed financing of Enodia Therapeutics, a ...
Medical Device Network on MSN
Enodia raises seed funding to advance protein degradation platform
Enodia Therapeutics has raised €20.7m ($25m) in seed funding to advance a small-molecule platform for targeted protein ...
The integration of bioinformatics, machine learning and multi-omics has transformed soil science, providing powerful tools to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback